Sign up to save your podcasts
Or
Share Ex-CDC director Tom Frieden on the next COVID-19 vaccines
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Ex-CDC director Tom Frieden on the next COVID-19 vaccines
Podcast: Axios Re:Cap (LS 54 · TOP 0.5% what is this?)
Episode: Ex-CDC director Tom Frieden on the next COVID-19 vaccines
Pub date: 2021-01-29
Get Podcast Transcript →
powered by Listen411 - fast audio-to-text and summarization
The podcast and artwork embedded on this page are from Axios, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
Episode: Ex-CDC director Tom Frieden on the next COVID-19 vaccines
Pub date: 2021-01-29
Get Podcast Transcript →
powered by Listen411 - fast audio-to-text and summarization
Americans fortunate enough to receive vaccines right now, outside of clinical trials, are getting ones made by either Pfizer or Moderna. But newly released data from Novavax and Johnson & Johnson suggests that more vaccines could be on the way. Dan digs into the news and why it matters, especially as COVID-19 variants begin to spread, with Tom Frieden, former head of the CDC.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The podcast and artwork embedded on this page are from Axios, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
View all episodes
By Listening Post / Listen Notes
3.8
1313 ratings
Podcast: Axios Re:Cap (LS 54 · TOP 0.5% what is this?)
Episode: Ex-CDC director Tom Frieden on the next COVID-19 vaccines
Pub date: 2021-01-29
Get Podcast Transcript →
powered by Listen411 - fast audio-to-text and summarization
The podcast and artwork embedded on this page are from Axios, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.
Episode: Ex-CDC director Tom Frieden on the next COVID-19 vaccines
Pub date: 2021-01-29
Get Podcast Transcript →
powered by Listen411 - fast audio-to-text and summarization
Americans fortunate enough to receive vaccines right now, outside of clinical trials, are getting ones made by either Pfizer or Moderna. But newly released data from Novavax and Johnson & Johnson suggests that more vaccines could be on the way. Dan digs into the news and why it matters, especially as COVID-19 variants begin to spread, with Tom Frieden, former head of the CDC.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The podcast and artwork embedded on this page are from Axios, which is the property of its owner and not affiliated with or endorsed by Listen Notes, Inc.